IMAF-Cape Fear

Overview

IMAF-Cape Fear is a member-owned and member-managed limited liability company, organized to provide members an opportunity for active involvement in a diversified capital investment process. The fund is part of the Inception Micro Angel Fund (IMAF), a family of seed stage angel capital funds designed to capitalize on the growth in entrepreneurial activity and venture financing, primarily in North Carolina and selective areas of Virginia and South Carolina. IMAF-Cape Fear focuses on early-stage, high-quality, and high-growth companies, primarily in the biotechnology, medical device, and life sciences sectors, located in or near the Cape Fear region of North Carolina. The fund typically invests between $50,000 and $250,000 per company, aiming to enhance the wealth creation of its members by investing both capital and time in these emerging companies. The fund is managed by Cornerstone Business Advisors, which assists entrepreneurs through business coaching, peer advisory boards, and private equity funding. As of May 2017, the fund has invested all of the capital raised and is currently in harvest mode, meaning it is no longer considering new investments. IMAF-Cape Fear's investment strategy involves a base of successful accredited investors from a variety of fields throughout the Cape Fear Region. These members actively participate in the investment process, attending screenings and monthly presentations, making personal add-on investments, and providing expertise during due diligence and in assisting portfolio companies. The fund seeks to invest in emerging, high-growth companies with highly scalable business models, preferably located in the Cape Fear region. Typical investments are between $50,000 and $250,000 per company, with the fund aiming to invest in up to 12 portfolio companies, depending upon the total amount of capital committed. The fund typically co-invests with other venture capital funds, angel groups, or high-net-worth individuals. The fund's portfolio includes companies such as 3Derm Inc., Groundfloor, Xanofi, Inc., Kwipped, Inc., Entigral Systems Inc., Next Glass, Inc., and Nirvana Sciences, Inc. These investments reflect the fund's commitment to supporting innovative companies in the biotechnology, medical device, and life sciences sectors. The fund's approach combines financial investment with active involvement from its members, leveraging their expertise and networks to support the growth and success of its portfolio companies.